Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker DAR
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Charles L. Adair Director | DAR Darling Ingredients Inc. | Buy | 500 | $51.19 | $25.6K Buy | Form 4 ↗ |
| Sep 2, 2026 | Randall C. Stuewe Chairman and CEO, Director | DAR Darling Ingredients Inc. | Sale | 5,000 | $68.20 | $341.0K Sale | Form 4 ↗ |
| Aug 18, 2026 | Joseph Manzi Chief Accounting Officer | DAR Darling Ingredients Inc. | Sale | 1,000 | $67.27 | $67.3K Sale | Form 4 ↗ |
| Aug 17, 2026 | Sandra Dudley EVP Chief Strategy Officer | DAR Darling Ingredients Inc. | Sale | 3,876 | $67.87 | $263.1K Sale | Form 4 ↗ |
| Aug 17, 2026 | Sandra Dudley EVP Chief Strategy Officer | DAR Darling Ingredients Inc. | Sale | 2,598 | $67.88 | $176.4K Sale | Form 4 ↗ |
| Aug 14, 2026 | Patrick McNutt EVP Chief Admin Officer | DAR Darling Ingredients Inc. | Sale | 8,000 | $67.09 | $536.7K Sale | Form 4 ↗ |
| Aug 13, 2026 | Randall C. Stuewe Chairman and CEO, Director | DAR Darling Ingredients Inc. | Sale | 5,000 | $64.79 | $323.9K Sale | Form 4 ↗ |
| Aug 12, 2026 | Randall C. Stuewe Chairman and CEO, Director | DAR Darling Ingredients Inc. | Sale | 5,000 | $63.26 | $316.3K Sale | Form 4 ↗ |
| Aug 10, 2026 | Nicholas James Kemphaus EVP Gen. Counsel & Secretary | DAR Darling Ingredients Inc. | Sale | 1,591 | $63.05 | $100.3K Sale | Form 4 ↗ |
| Jul 31, 2026 | Charles L. Adair Director | DAR Darling Ingredients Inc. | Buy | 500 | $61.27 | $30.6K Buy | Form 4 ↗ |
| Jul 31, 2026 | Charles L. Adair Director | DAR Darling Ingredients Inc. | Buy | 500 | $60.67 | $30.3K Buy | Form 4 ↗ |
| May 1, 2026 | Joseph Manzi Chief Accounting Officer | DAR Darling Ingredients Inc. | Sale | 3,000 | $63.89 | $191.7K Sale | Form 4 ↗ |
| Mar 6, 2026 | Randall C. Stuewe Chairman and CEO, Director | DAR Darling Ingredients Inc. | Sale | 20,000 | $52.12 | $1.0M Sale | Form 4 ↗ |
| Feb 18, 2026 | Jan van der Velden EVP Int Rendering&Specialties | DAR Darling Ingredients Inc. | Sale | 3,000 | $51.29 | $153.9K Sale | Form 4 ↗ |
| Feb 17, 2026 | Jan van der Velden EVP Int Rendering&Specialties | DAR Darling Ingredients Inc. | Sale | 20,000 | $51.22 | $1.0M Sale | Form 4 ↗ |
| Feb 13, 2026 | Sandra Dudley EVP Chief Strategy Officer | DAR Darling Ingredients Inc. | Sale | 2,331 | $51.76 | $120.7K Sale | Form 4 ↗ |
| Feb 13, 2026 | Sandra Dudley EVP Chief Strategy Officer | DAR Darling Ingredients Inc. | Sale | 1,464 | $51.57 | $75.5K Sale | Form 4 ↗ |
| Feb 13, 2026 | Sandra Dudley EVP Chief Strategy Officer | DAR Darling Ingredients Inc. | Sale | 4,856 | $51.86 | $251.8K Sale | Form 4 ↗ |
| Feb 13, 2026 | Nicholas James Kemphaus EVP Gen. Counsel & Secretary | DAR Darling Ingredients Inc. | Sale | 3 | $52.56 | $158 Sale | Form 4 ↗ |
| Feb 13, 2026 | Nicholas James Kemphaus EVP Gen. Counsel & Secretary | DAR Darling Ingredients Inc. | Sale | 620 | $51.96 | $32.2K Sale | Form 4 ↗ |
| Feb 13, 2026 | Nicholas James Kemphaus EVP Gen. Counsel & Secretary | DAR Darling Ingredients Inc. | Sale | 2,546 | $52.29 | $133.1K Sale | Form 4 ↗ |
| Feb 13, 2026 | Nicholas James Kemphaus EVP Gen. Counsel & Secretary | DAR Darling Ingredients Inc. | Sale | 2,661 | $52.03 | $138.5K Sale | Form 4 ↗ |
| Aug 18, 2025 | Randall C. Stuewe Chairman and CEO, Director | DAR Darling Ingredients Inc. | Sale | 35,000 | $30.92 | $1.1M Sale | Form 4 ↗ |
| Aug 15, 2025 | Randall C. Stuewe Chairman and CEO, Director | DAR Darling Ingredients Inc. | Sale | 27,500 | $31.17 | $857.2K Sale | Form 4 ↗ |
| Aug 12, 2025 | John F. Sterling EVP Gen. Counsel & Secretary | DAR Darling Ingredients Inc. | Sale | 35,000 | $31.13 | $1.1M Sale | Form 4 ↗ |
| Aug 4, 2025 | Randall C. Stuewe Chairman and CEO, Director | DAR Darling Ingredients Inc. | Sale | 7,500 | $31.62 | $237.2K Sale | Form 4 ↗ |
| May 19, 2025 | Randall C. Stuewe Chairman and CEO, Director | DAR Darling Ingredients Inc. | Sale | 40,000 | $34.05 | $1.4M Sale | Form 4 ↗ |
| Nov 19, 2024 | Randall C. Stuewe Chairman and CEO, Director | DAR Darling Ingredients Inc. | Sale | 24,710 | $41.95 | $1.0M Sale | Form 4 ↗ |
| Nov 18, 2024 | Randall C. Stuewe Chairman and CEO, Director | DAR Darling Ingredients Inc. | Sale | 290 | $43.00 | $12.5K Sale | Form 4 ↗ |
29 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:41 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances